Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVipera Regulatory News (VIP)

Share Price Information for Vipera (VIP)

Share Price is delayed by 15 minutes
Get Live Data
201.50    7.50 (3.87%)
Bid:
194.00
Ask:
209.00
Spread: 15.00 (7.732%)
Market Cap: £82.54m
VIP Live PriceLast checked at - London Stock Exchange

Intraday Vipera Share Chart

Tender Offer

1 Aug 2025 15:34

RNS Number : 6954T
Value and Indexed Prop Inc Tst PLC
01 August 2025
 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION

 

For immediate release

1 August 2025

 

Value and Indexed Property Income Trust PLC (the "Company")

Legal Entity Identifier: 213800CU1PIC7GAER820 

Proposed Tender Offer, Fixed Life and Discount Control Policy

 

The Company is pleased to announce its intention to bring forward its proposals to offer shareholders a cash exit by way of tender offer. The Company is also proposing to fix the life of the Company and adopt a discount control policy. These proposals follow the conversion of the Company to REIT status on 1 April 2025 which marked the completion of the transition of the Company from a mainly equity-based investment trust to a real estate investment trust.

PROPOSED TENDER OFFER

The Company intends to undertake a tender offer at a fixed tender price (to be announced soon) ("Tender Price") calculated on the basis of the NAV per share as at 31 March 2025 less costs (the "Proposed Tender Offer"). 

The Proposed Tender Offer will allow the Company to make an offer to all shareholders, on the same terms, expected to be for 30 per cent. of the Company's shares in issue, other than those held by the directors and associates who will not be tendering their shares. Shareholders may, if they wish, tender a higher percentage, through an excess tender facility, to the extent that other shareholders do not take up their entitlement.

At the same time, shareholders who wish to increase their shareholding in the Company would be able to do so, at the Tender Price, by buying shares from exiting shareholders through the mix and match facility. New investors may also be able to buy shares, at the Tender Price, once the demand from existing shareholders is satisfied. The Board also intends to issue shares, currently held in Treasury, at the Tender Price, if there is demand from first existing shareholders and then new investors.

The Company intends to consult with the Takeover Panel with a view to seeking a waiver of the requirement for any concert party to make a general offer to all shareholders under Rule 9 of the Takeover Code in connection with the Proposed Tender Offer.

The Proposed Tender Offer and the Takeover Panel waiver will be subject to approval at a general meeting of the Company (the "General Meeting") to be convened soon. 

The full terms of the Proposed Tender Offer together the further details on the background and why the Board considers the Proposed Tender Offer and its future plans are in the best interests of shareholders as a whole will be set out in a circular which will be published and sent to shareholders soon.

FUTURE PLANS

The Board has also determined that it would be in the best interests of shareholders as a whole to introduce an obligation on the Directors to propose a resolution to wind up the Company or other such form of exit proposal provided any such proposal has as its objective the discontinuation of the Company at a general meeting to be held on or prior to 31 March 2033. This coincides with the expiry of the Company's current fixed rate loan and the Company will not take out any further loans with an expiry date after 31 March 2033. 

The Board, therefore, intends to propose, at the General Meeting, an amendment to the Company's Articles of Association to introduce this obligation and provide shareholders with a guaranteed exit opportunity.

In addition the Board would, after the completion of the Proposed Tender Offer, adopt a discount control policy which would aim to keep the Company's share price discount to net asset value between 0 per cent. and 10 per cent. in normal circumstances at the Directors discretion.

Should the Company's shares trade at a premium to NAV, the Company would aim to issue shares in the market.

It is also intended that independent valuations of the Company's property portfolio would take place on a quarterly basis instead of half-yearly as at present.

For further information please contact:

 

Maven Capital Partners UK LLP

Tel: +44 (0) 141 306 7400

Company Secretary

Mandy Kelly

 

Dickson Minto Advisers LLP

Tel: +44 (0) 20 7649 6933

Financial Adviser

Fiona Thompson

 

Shore Capital

Tel: +44 (0) 20 7408 4050

Joint Corporate Broker

Gillian Martin / Anita Ghanekar / Matthew Walton (Corporate Advisory)

Ben Canning / Fiona Conroy (Corporate Broking)

 

Berenberg

Tel: +44 (0) 203 207 7882

Joint Corporate Broker

Carl Gough / Patrick Dolaghan

This announcement is released by the Company and the information contained within this announcement is deemed by the Company to constitute inside information for the purposes of Article 7 of the UK version of the EU Market Abuse Regulation (Regulation (EU) No.596/2014) which forms part of UK law by virtue of the European Union (Withdrawal) Act 2018, as amended. Upon the publication of this announcement via a Regulatory Information Service, such information is now considered to be in the public domain.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TENPBMITMTJMBJA
Date   Source Headline
15th May 20267:00 amRNSFixed Rate Borrowings and Property Purchase
20th Apr 20267:00 amRNSIssue of Shares from Treasury
10th Apr 20263:58 pmRNSInvestor Meet Presentation
1st Apr 20264:59 pmRNSHolding(s) in Company
1st Apr 20264:15 pmRNSIssue of Shares from Treasury
1st Apr 20267:05 amRNSStatement re MAR
1st Apr 20267:00 amRNSPortfolio Update and Year End Portfolio Valuation
19th Mar 20264:39 pmRNSTransaction in Own Shares
18th Mar 20264:59 pmRNSTransaction in Own Shares
23rd Feb 20267:00 amRNSDividend Declaration
5th Jan 20267:00 amRNSPortfolio Update and 31 December 2025 Valuation
5th Dec 202512:27 pmRNSDirector/PDMR Shareholding
5th Dec 202512:25 pmRNSHolding(s) in Company
5th Dec 202512:25 pmRNSHolding(s) in Company
24th Nov 20255:00 pmRNSHolding(s) in Company
24th Nov 202511:39 amRNSDividend Declaration
19th Nov 20257:00 amRNSTransaction in Own Shares - Replacement
18th Nov 20255:18 pmRNSTransaction in Own Shares
18th Nov 20253:19 pmRNSInvestor Presentation
17th Nov 20257:00 amRNSHalf-year Financial Report
9th Oct 20257:00 amRNSPortfolio Update, Valuation, Borrowings and Tender
29th Sep 20257:00 amRNSResult of Tender Offer
25th Sep 20254:30 pmRNSResults of General Meeting
2nd Sep 20257:28 amRNSDividend Declaration
2nd Sep 20257:00 amRNSCirc re. Tender Offer
1st Aug 20253:34 pmRNSTender Offer
1st Aug 20253:30 pmRNSStatement re Financial Adviser & Corporate Broker
10th Jul 20253:25 pmRNSResult of AGM
11th Jun 20257:00 amRNSAnnual Financial Report
2nd Apr 20258:05 amRNSTrading Statement
1st Apr 20251:24 pmRNSStatement re tax status
31st Mar 20257:00 amRNSTransaction in Own Shares
21st Mar 20255:01 pmRNSTransaction in Own Shares
20th Mar 20251:59 pmRNSDeclaration of Third Quarterly Dividend
20th Mar 20251:48 pmRNSResult of General Meeting
19th Mar 20255:19 pmRNSTransaction in Own Shares
13th Mar 20255:07 pmRNSTransaction in Own Shares
3rd Mar 20255:06 pmRNSTransaction in Own Shares
27th Feb 20255:05 pmRNSTransaction in Own Shares
25th Feb 202512:31 pmRNSPublication of Circular
24th Feb 20255:17 pmRNSTransaction in Own Shares
21st Feb 20254:51 pmRNSTransaction in Own Shares
20th Feb 20254:55 pmRNSTransaction in Own Shares
19th Feb 20255:05 pmRNSTransaction in Own Shares
14th Feb 20255:32 pmRNSTransaction in Own Shares
28th Jan 20254:54 pmRNSTransaction in Own Shares
27th Jan 20254:58 pmRNSTransaction in Own Shares
21st Jan 20255:13 pmRNSTransaction in Own Shares
9th Jan 20257:00 amRNSTransaction in Own Shares
7th Jan 20255:07 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.